By 36 krypton

Watson已經和世界各地的不少知名醫院進行合作,在中國也進入了21家三甲醫院的診療系統。表面上看來,Watson在未來的醫療領域大有可為,但是在最近一年中,我們聽到了更多不同的聲音。

在去年,IBM Watson和休斯敦安德森癌症研究中心(MD Anderson Cancer Center)分道揚鑣,IBM股價受到影響;在今年的7月2日,《富比士》評論員Jason Bloomberg更是發文質疑IBM Watson是否「是個笑話」。

Read the entire article at https://www.bnext.com.tw/article/45393/ibm-watson-meet-its-obstacles

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our Cortex & Brain Candy Newsletters!

Thank you for reading Intellyx thought leadership!

Please sign up for our biweekly Cortex and Brain Candy newsletters.

The Cortex features thought leadership on Agile Digital Transformation topics, and Brain Candy highlights disruptive vendors in enterprise IT.

We won't spam you and you can unsubscribe at any time.